Serenis, 12 million round led by Angelini Ventures and Cdp Venture Capital

Online mental and physical health platform Serenis, with 1.5 million sessions under its belt, announced a capital increase of EUR 12 million. The Series A round, which follows two funding rounds bringing total funding to a value of 20 million, was led by Angelini Ventures and Cdp Venture Capital. Angelini Industries' venture capital fund, which manages capital of EUR 300 million for investments in innovative healthcare solutions, also supported Serenis in its first round of funding in 2022.

"We are proud to have believed in Serenis from the very beginning and to accompany its growth today, taking on the role of lead investor. Investing in Serenis means believing that mental and physical wellbeing should be accessible to everyone. For Angelini Ventures it is a source of pride to support a team that, with clinical rigour and innovation, is building an accessible and sustainable model of digital and in-person care, destined to become a benchmark in Italy,' commented Elia Stupka, managing director of Angelini Ventures.

Cdp Venture Capital participated in the capital increase through the Digital Transition Fund, using resources allocated by the EU through the NextGeneration EU initiative to facilitate the digital transition of supply chains and small and medium-sized enterprises. The operation saw the participation of Azimut Libera Impresa, X-Equity Venture Club Srl, Invictus Capital, Lumen Ventures, FG2 Capital, and the entry of additional new investors such as, Club degli Investitori, and Doorway.

"We decided to support Serenis because it represents one of the most promising realities on the digital health scene in Europe, with an admirable ability to integrate technology, clinical expertise and social impact," said Enrico Filì, head of Cdp Venture Capital's Digital transition fund, adding: "The launch of Serenis Nutrition and the evolution envisaged in the business plan confirm a clear and ambitious vision. We are excited to accompany the team in this new phase of growth'.

The achievement of this round will allow for the continuation of the expansion of the digital medical care services offering that will follow the launch of Serenis Nutrition. The service, which was introduced during 2025, will see its consolidation in 2026 with an expansion of the offering to offer increasingly cutting-edge pathways.